Literature DB >> 11521699

Radiotherapy of exudative age-related macular degeneration; a clinical and pathologic study.

A C Lambooij1, R W Kuijpers, C M Mooy, M Kliffen.   

Abstract

BACKGROUND: Radiotherapy has recently been employed to treat patients with exudative macular degeneration in order to prevent severe visual loss. Radiotherapy affects the evolution of exudative macular degeneration directly by endothelial toxicity, leading to capillary closure, and/or indirectly through its attenuating effects on the inflammatory response, mediated by macrophages and other inflammatory cells.
METHODS: In this study we describe the histopathologic findings in a patient with exudative age-related macular degeneration (AMD) in both eyes whose right eye was treated with radiotherapy (5 times 2 Gy) 3 years before he died. The eyes were enucleated post mortem and investigated by light microscopy. Additionally, immunohistochemical investigation with antibodies against CD34 and CD68 was performed to identify patent endothelial cells and macrophages.
RESULTS: Both eyes showed neovascular AMD consisting of mixed fibrocellular and fibrovascular membranes. Capillaries in both the choriocapillaris and the neovascular membrane were patent in both eyes. Macrophages were present in the choroidal neovascularization of both eyes. Neither preexistent choroidal, intraretinal, nor neovascular vessels showed increased wall thickness as sign of radiation damage.
CONCLUSION: No radiation-related histopathologic effect could be demonstrated 3 years after radiation therapy in this patient with AMD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11521699     DOI: 10.1007/s004170100314

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  2 in total

1.  Clinicopathological correlation of choroidal neovascularization after external beam radiotherapy in age-related macular degeneration.

Authors:  S Aisenbrey; B A Lafaut; S Reynders; P Szurman; S Grisanti; C Vanden Broecke; P Walter; K U Bartz-Schmidt
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-03-22       Impact factor: 3.117

Review 2.  Epimacular brachytherapy for wet AMD: current perspectives.

Authors:  Ricardo P Casaroli-Marano; Socorro Alforja; Joan Giralt; Michel E Farah
Journal:  Clin Ophthalmol       Date:  2014-08-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.